Unknown

Dataset Information

0

Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.


ABSTRACT: The development of a new series of apoptosis signal-regulating kinase 1 (ASK1) inhibitors is described. Starting from purine, pyrimidine and quinazoline scaffolds identified by high throughput screening, we used tools of structure-based drug design to develop a series of potent kinase inhibitors, including 2-arylquinazoline derivatives 12 and 23, with submicromolar inhibitory activities against ASK1. Kinetic analysis demonstrated that the 2-arylquinazoline scaffold ASK1 inhibitors described herein are ATP competitive.

SUBMITTER: Monastyrskyi A 

PROVIDER: S-EPMC5999544 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.

Monastyrskyi Andrii A   Bayle Simon S   Quereda Victor V   Grant Wayne W   Cameron Michael M   Duckett Derek D   Roush William W  

Bioorganic & medicinal chemistry letters 20171213 3


The development of a new series of apoptosis signal-regulating kinase 1 (ASK1) inhibitors is described. Starting from purine, pyrimidine and quinazoline scaffolds identified by high throughput screening, we used tools of structure-based drug design to develop a series of potent kinase inhibitors, including 2-arylquinazoline derivatives 12 and 23, with submicromolar inhibitory activities against ASK1. Kinetic analysis demonstrated that the 2-arylquinazoline scaffold ASK1 inhibitors described here  ...[more]

Similar Datasets

| S-EPMC6272711 | biostudies-literature
| S-EPMC4601062 | biostudies-literature
| S-EPMC7659976 | biostudies-literature
| S-EPMC6982996 | biostudies-literature
| S-EPMC7153032 | biostudies-literature
| S-EPMC4789664 | biostudies-literature
| S-EPMC7822064 | biostudies-literature
| S-EPMC7641325 | biostudies-literature